FATIMA EIDY: Open Payments
NPI 1780193748 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 75 payments from 23 companies in 2025. Trend: 2023 $1,601 · 2024 $984 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $305 |
| Novo Nordisk Inc | 10 | $180 |
| Ardelyx, Inc. | 6 | $93 |
| Amgen Inc. | 5 | $82 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| CeQur Corporation | 1 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| PFIZER INC. | 3 | $63 |
| Exact Sciences Corporation | 3 | $60 |
| ABBVIE INC. | 3 | $60 |
Products named: IBSRELA, AIRSUPRA, BREZTRI, CeQur Simplicity, Kerendia, CREON, GEMTESA, Auvelity.
Industry payments across MI — which companies pay providers there.
